PTEN Activity ELISA Kit

Article Name:	PTEN Activity ELISA Kit
Biozol Catalog Number:	ECH-K-4700
Supplier Catalog Number:	K-4700
Alternative Catalog Number:	ECH-K-4700-1KIT
Manufacturer:	Echelon Biosciences
Category:	Molekularbiologie

The PTEN Activity ELISA is designed to quantify the phosphatase activity of PTEN by detection of the enzyme product, PI(4,5)P2. Sample Type: Recombinant or immunoprecipitated PTEN enzyme (IP protocol at end of Technical Data Sheet) Assay Range: 12.5 to 200 pmol PI(4,5)P2

Product Background The PTEN Activity ELISA directly detects the phosphoinositide product. Other assays detect free phosphate. This eliminates many possible sources of error due to the fact that inorganic phosphate is the product of many phosphatase enzyme activities, and is found in common buffers and cleaning products. The assay is a competitive ELISA in which the signal is inversely proportional to the amount of PI(4,5)P2 produced. After the PTEN reactions are complete, reaction products are added to the PI(4,5)P2-coated microplate and a PI(4,5)P2 detector protein is added for competitive binding. A peroxidase-linked secondary detector and colorimetric detection is used to detect PI(4,5)P2 detector binding to the plate. The colorimetric signal is inversely proportional to the amount of PI(4,5)P2 produced by PTEN. PTEN (Phosphatase and Tensin Homolog deleted on Chromosome 10) is a 3 phosphoinositide phosphatase that converts PI(3,4,5)P3 to PI(4,5)P2, thus opposing PKB/Akt activation by PI 3-K. PTEN is involved in neuronal stem cell proliferation and self-renewal, cardiac myocyte hypertrophy and contractility, and a wide range of developmental processes. PTEN, however, is best known for its role as a tumor suppressor. Loss of PTEN activity results in accumulation of PI(3,4,5)P3, abnormal activation of PKB/Akt, unregulated cell growth, suppression of apoptosis, and increased tumorigenesis in a number of human tissues. It has also been proposed that PTEN is a candidate for targeted chemotherapy because certain anti-cancer agents preferentially destroy tumors with PTEN mutations. In addition to this direct role in cancer, PTEN has recently been shown to regulate cancer-associated pathways including VEGF-mediated angiogenesis and others. Featured in Publications: 1. Tzenaki, N., M. Aivaliotis, et al. (2015). Focal adhesion kinase phosphorylates the phosphatase and tensin homolog deleted on chromosome 10 under the control of p110i´ phosphoinositide-3 kinase. Faseb J. doi:10.1096/fj.15-274589 2. Guo, S. T., M. N. Chi, et al. (2015). INPP4B is an oncogenic regulator in human colon cancer. Oncogene. doi:10.1038/onc.2015.361 3. Tsai, C.-Y., et al. (2017). PTEN, a negative regulator of PI3K/Akt signaling, sustains brain stem cardiovascular regulation during mevinphos intoxication. Neuropharmacology 123(1): 175-185. 4. Fang, C., et al. (2019). ZFYVE21 is a complement-induced Rab5 effector that activates non-canonical NF-kappaB via phosphoinosotide remodeling of endosomes. Nature Communications 10(1): 2247. 5. Zhou, X., et al. (2019). The deubiquitinase Otub1 controls the activation of CD8+ T cells and NK cells by regulating IL-15-mediated priming. Nature Immunology 20: 879-889.

Documents Technical Data Sheet

Application Notes:

Categories: Bioassays & Kits. Related: Activity, ELISA, PTEN. Ship 1 : Shipping Temp. Ship 2: Dry ice and / or gel ice depending on destination - product may ship in two boxes